Use of plethysmography in assessing the efficacy of antivirals in a mouse model of pandemic influenza A virus

Antiviral Research

Volumn 92, Issue 2, 2011, Pages 228-236

  Julander, Justin G ^a   Hagloch, Joe ^a   Latimer, Scott ^a   Motter, Neil ^a   Dagley, Ashley ^a   Barnard, Dale L ^a   Smee, Donald F ^a   Morrey, John D ^a  

^a UTAH STATE UNIVERSITY   (United States)

Author keywords

Antiviral; Combination; Influenza; Lung function; Mouse; Plethysmography

Indexed keywords

OSELTAMIVIR; RIBAVIRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; INFLUENZA A; INFLUENZA VIRUS A; LUNG FUNCTION; LUNG WEIGHT; MOUSE; NONHUMAN; PANDEMIC INFLUENZA; PLETHYSMOGRAPHY; PRIORITY JOURNAL; TREATMENT RESPONSE; WEIGHT CHANGE; WEIGHT REDUCTION;

ANIMALS; ANTIVIRAL AGENTS; DRUG MONITORING; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; OSELTAMIVIR; PLETHYSMOGRAPHY; RIBAVIRIN; TREATMENT OUTCOME;

INFLUENZA A VIRUS; MUS; SUIDAE;

EID: 80054855056     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.08.011     Document Type: Article

References (30)

1. Adler A., Cieslewicz G., Irvin C.G. Unrestrained plethysmography is an unreliable measure of airway responsiveness in BALB/c and C57BL/6 mice. J. Appl. Physiol. 2004, 97:286-292.
2. Bantia S., Kellogg D., Parker C., Upshaw R., Ilyushina N.A., Babu Y.S. A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A/California/04/2009 (H1N1) influenza virus infection in mice. Antiviral Res. 2011, 90:17-21.
3. Bates J.H., Thompson-Figueroa J., Lundblad L.K., Irvin C.G. Unrestrained video-assisted plethysmography: a noninvasive method for assessment of lung mechanical function in small animals. J. Appl. Physiol. 2008, 104:253-261.
4. Bogs J., Veits J., Gohrbandt S., Hundt J., Stech O., Breithaupt A., Teifke J.P., Mettenleiter T.C., Stech J. Highly pathogenic H5N1 influenza viruses carry virulence determinants beyond the polybasic hemagglutinin cleavage site. PLoS ONE 2010, 5:e11826.
5. Boukhvalova M.S., Sotomayor T.B., Point R.C., Pletneva L.M., Prince G.A., Blanco J.C. Activation of interferon response through toll-like receptor 3 impacts viral pathogenesis and pulmonary toll-like receptor expression during respiratory syncytial virus and influenza infections in the cotton rat Sigmodon hispidus model. Journal of Interferon & Cytokine Research: The Official Journal of the International Society for Interferon and Cytokine Research 2010, 30:229-242.
6. de Vrankrijker A.M., Wolfs T.F., Ciofu O., Hoiby N., van der Ent C.K., Poulsen S.S., Johansen H.K. Respiratory syncytial virus infection facilitates acute colonization of Pseudomonas aeruginosa in mice. J. Med. Virol. 2009, 81:2096-2103.
7. Govorkova E.A., Marathe B.M., Prevost A., Rehg J.E., Webster R.G. Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets. Antiviral Res. 2011, 91:81-88.
8. Hamelin M.E., Gagnon C., Prince G.A., Kiener P., Suzich J., Ulbrandt N., Boivin G. Prophylactic and therapeutic benefits of a monoclonal antibody against the fusion protein of human metapneumovirus in a mouse model. Antiviral Res. 2010, 88:31-37.
9. Higuera Iglesias A.L., Kudo K., Manabe T., Corcho Berdugo A.E., Baeza A.C., Ramos L.A., Gutierrez R.G., Manjarrez Zavala M.E., Takasaki J., Izumi S., Bautista E., Perez Padilla J.R. Reducing occurrence and severity of Pneumonia due to pandemic H1N1 2009 by early Oseltamivir administration: a retrospective study in Mexico. PLoS ONE 2011, 6:e21838.
10. Kim T.S., Sun J., Braciale T.J. T cell responses during influenza infection: getting and keeping control. Trends Immunol. 2011.
11. Lundblad L.K., Irvin C.G., Adler A., Bates J.H. A reevaluation of the validity of unrestrained plethysmography in mice. J. Appl. Physiol. 2002, 93:1198-1207.
12. Maines T.R., Chen L.M., Belser J.A., Van Hoeven N., Smith E., Donis R.O., Tumpey T.M., Katz J.M. Multiple genes contribute to the virulent phenotype observed in ferrets of an H5N1 influenza virus isolated from Thailand in 2004. Virology 2011, 413:226-230.
13. Marsland B.J., Scanga C.B., Kopf M., Le Gros G. Allergic airway inflammation is exacerbated during acute influenza infection and correlates with increased allergen presentation and recruitment of allergen-specific T-helper type 2 cells. Clin. Exp. Allergy 2004, 34:1299-1306.
14. McGill J., Heusel J.W., Legge K.L. Innate immune control and regulation of influenza virus infections. J. Leukoc. Biol. 2009, 86:803-812.
15. Monsalvo A.C., Batalle J.P., Lopez M.F., Krause J.C., Klemenc J., Hernandez J.Z., Maskin B., Bugna J., Rubinstein C., Aguilar L., Dalurzo L., Libster R., Savy V., Baumeister E., Cabral G., Font J., Solari L., Weller K.P., Johnson J., Echavarria M., Edwards K.M., Chappell J.D., Crowe J.E., Williams J.V., Melendi G.A., Polack F.P. Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat. Med. 2011, 17:195-199.
16. Sidwell R.W., Huffman J.H., Gilbert J., Moscon B., Pedersen G., Burger R., Warren R.P. Utilization of pulse oximetry for the study of the inhibitory effects of antiviral agents on influenza virus in mice. Antimicrob. Agents Chemother. 1992, 36:473-476.
17. Sidwell R.W., Bailey K.W., Wong M.H., Barnard D.L., Smee D.F. In vitro and in vivo influenza virus-inhibitory effects of viramidine. Antiviral Res. 2005, 68:10-17.
18. Sidwell R.W., Barnard D.L., Day C.W., Smee D.F., Bailey K.W., Wong M.H., Morrey J.D., Furuta Y. Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice. Antimicrob. Agents Chemother. 2007, 51:845-851.
19. Smee D.F., Hurst B.L., Wong M.H., Bailey K.W., Morrey J.D. Effects of double combinations of Amantadine, Oseltamivir, and Ribavirin on influenza A (H5N1) virus infections in cell culture and in mice. Antimicrob. Agents Chemother. 2009, 53:2120-2128.
20. Smee D.F., Hurst B.L., Wong M.H., Bailey K.W., Tarbet E.B., Morrey J.D., Furuta Y. Effects of the combination of Favipiravir (T-705) and Oseltamivir on influenza A virus infections in mice. Antimicrob. Agents Chemother. 2010, 54:126-133.
21. Smee D.F., Hurst B.L., Wong M.H., Tarbet E.B., Babu Y.S., Klumpp K., Morrey J.D. Combinations of Oseltamivir and Peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice. Antiviral Res. 2010, 88:38-44.
22. Snelgrove R.J., Edwards L., Rae A.J., Hussell T. An absence of reactive oxygen species improves the resolution of lung influenza infection. Eur. J. Immunol. 2006, 36:1364-1373.
23. Srikiatkhachorn A., Chintapalli J., Liu J., Jamaluddin M., Harrod K.S., Whitsett J.A., Enelow R.I., Ramana C.V. Interference with intraepithelial TNF-alpha signaling inhibits CD8(+) T-cell-mediated lung injury in influenza infection. Viral Immunol. 2010, 23:639-645.
24. Stowell N.C., Seideman J., Raymond H.A., Smalley K.A., Lamb R.J., Egenolf D.D., Bugelski P.J., Murray L.A., Marsters P.A., Bunting R.A., Flavell R.A., Alexopoulou L., San Mateo L.R., Griswold D.E., Sarisky R.T., Mbow M.L., Das A.M. Long-term activation of TLR3 by poly(I:C) induces inflammation and impairs lung function in mice. Respir. Res. 2009, 10:43.
25. Van Kerkhove M.D., Vandemaele K.A., Shinde V., Jaramillo-Gutierrez G., Koukounari A., Donnelly C.A., Carlino L.O., Owen R., Paterson B., Pelletier L., Vachon J., Gonzalez C., Hongjie Y., Zijian F., Chuang S.K., Au A., Buda S., Krause G., Haas W., Bonmarin I., Taniguichi K., Nakajima K., Shobayashi T., Takayama Y., Sunagawa T., Heraud J.M., Orelle A., Palacios E., van der Sande M.A., Wielders C.C., Hunt D., Cutter J., Lee V.J., Thomas J., Santa-Olalla P., Sierra-Moros M.J., Hanshaoworakul W., Ungchusak K., Pebody R., Jain S., Mounts A.W. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: A global pooled analysis. PLoS Med. 2011, 8:e1001053.
26. Verhoeven D., Teijaro J.R., Farber D.L. Pulse-oximetry accurately predicts lung pathology and the immune response during influenza infection. Virology 2009, 390:151-156.
27. Vlahos R., Stambas J., Bozinovski S., Broughton B.R., Drummond G.R., Selemidis S. Inhibition of Nox2 oxidase activity ameliorates influenza A virus-induced lung inflammation. PLoS Pathog. 2011, 7:e1001271.
28. Wong J.P., Saravolac E.G., Sabuda D., Levy H.B., Kende M. Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in mice. Antimicrob. Agents Chemother. 1995, 39:2574-2576.
29. Wong J.P., Christopher M.E., Viswanathan S., Karpoff N., Dai X., Das D., Sun L.Q., Wang M., Salazar A.M. Activation of toll-like receptor signaling pathway for protection against influenza virus infection. Vaccine 2009, 27:3481-3483.
30. Zhou B., Li Y., Halpin R., Hine E., Spiro D.J., Wentworth D.E. PB2 residue 158 is a pathogenic determinant of pandemic H1N1 and H5 influenza a viruses in mice. J. Virol. 2011, 85:357-365.